SCHEMBL19626600

SCHEMBL19626600

CCN(CC)c1ccc(-c2nc(C)sc2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 1/20 0.41
GRIA2 P42262 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
ALDH1A1 P00352 7/20 0.38
MAPT P10636 5/20 0.38
HPGD P15428 4/20 0.38
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 2/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPK1 P28482 2/20 0.38
CYP3A4 P08684 2/20 0.38
PSMD14 O00487 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626665 0.81 GAA (0.44) TERTALDH1A1MAPTHPGDKDM4E
SCHEMBL19625452 0.81 PTGS2 (0.40) TERTGRIA2GRIN1GRIN2AALDH1A1
SCHEMBL19626771 0.81 DHFR (0.38) TERTALDH1A1MAPTHPGDKDM4E
SCHEMBL19626781 0.80 CYP3A4 (0.40) TERTGRIA2GRIN1GRIN2AALDH1A1
SCHEMBL19626651 0.78 PTGS2 (0.56) ALDH1A1MAPTKDM4ESMN1; SMN2LMNA
SCHEMBL19626765 0.77 GRIA2 (0.32) TERTGRIA2GRIN1GRIN2AALDH1A1
SCHEMBL19626656 0.76 PPARD (0.41) TERTGRIA2GRIN1GRIN2AALDH1A1
SCHEMBL19626744 0.75 PTGDR2 (0.53) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17625955 0.72 ALDH1A1 (0.40) TERTALDH1A1MAPTKDM4ENPC1
SCHEMBL19626588 0.70 ALDH1A1 (0.42) TERTGRIA2GRIN1GRIN2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 TERT 2609/4885GRIA2 3043/4885GRIN1 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.